Menu
GeneBe

10-94171182-C-T

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 1P and 13B. PP2BP4_StrongBP6BS1BS2

The NM_016341.4(PLCE1):​c.1495C>T​(p.Arg499Cys) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0021 in 1,613,902 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R499H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0022 ( 3 hom. )

Consequence

PLCE1
NM_016341.4 missense, splice_region

Scores

7
6
6

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: 5.28
Variant links:
Genes affected
PLCE1 (HGNC:17175): (phospholipase C epsilon 1) This gene encodes a phospholipase enzyme that catalyzes the hydrolysis of phosphatidylinositol-4,5-bisphosphate to generate two second messengers: inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG). These second messengers subsequently regulate various processes affecting cell growth, differentiation, and gene expression. This enzyme is regulated by small monomeric GTPases of the Ras and Rho families and by heterotrimeric G proteins. In addition to its phospholipase C catalytic activity, this enzyme has an N-terminal domain with guanine nucleotide exchange (GEF) activity. Mutations in this gene cause early-onset nephrotic syndrome; characterized by proteinuria, edema, and diffuse mesangial sclerosis or focal and segmental glomerulosclerosis. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

PP2
Missense variant where missense usually causes diseases, PLCE1
BP4
Computational evidence support a benign effect (MetaRNN=0.026130855).
BP6
Variant 10-94171182-C-T is Benign according to our data. Variant chr10-94171182-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 301699.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=2, Likely_benign=2}. Variant chr10-94171182-C-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00129 (197/152300) while in subpopulation NFE AF= 0.0025 (170/68024). AF 95% confidence interval is 0.00219. There are 0 homozygotes in gnomad4. There are 89 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PLCE1NM_016341.4 linkuse as main transcriptc.1495C>T p.Arg499Cys missense_variant, splice_region_variant 4/33 ENST00000371380.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PLCE1ENST00000371380.8 linkuse as main transcriptc.1495C>T p.Arg499Cys missense_variant, splice_region_variant 4/331 NM_016341.4 P1Q9P212-1

Frequencies

GnomAD3 genomes
AF:
0.00129
AC:
197
AN:
152182
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000386
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.000283
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00250
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00170
AC:
423
AN:
248656
Hom.:
0
AF XY:
0.00176
AC XY:
237
AN XY:
135006
show subpopulations
Gnomad AFR exome
AF:
0.000452
Gnomad AMR exome
AF:
0.000550
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000719
Gnomad FIN exome
AF:
0.000464
Gnomad NFE exome
AF:
0.00319
Gnomad OTH exome
AF:
0.000991
GnomAD4 exome
AF:
0.00219
AC:
3195
AN:
1461602
Hom.:
3
Cov.:
31
AF XY:
0.00208
AC XY:
1511
AN XY:
727130
show subpopulations
Gnomad4 AFR exome
AF:
0.000329
Gnomad4 AMR exome
AF:
0.000514
Gnomad4 ASJ exome
AF:
0.000153
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000684
Gnomad4 FIN exome
AF:
0.000599
Gnomad4 NFE exome
AF:
0.00268
Gnomad4 OTH exome
AF:
0.00149
GnomAD4 genome
AF:
0.00129
AC:
197
AN:
152300
Hom.:
0
Cov.:
32
AF XY:
0.00120
AC XY:
89
AN XY:
74452
show subpopulations
Gnomad4 AFR
AF:
0.000385
Gnomad4 AMR
AF:
0.000327
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000415
Gnomad4 FIN
AF:
0.000283
Gnomad4 NFE
AF:
0.00250
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.00236
Hom.:
1
Bravo
AF:
0.00141
TwinsUK
AF:
0.00243
AC:
9
ALSPAC
AF:
0.00337
AC:
13
ESP6500AA
AF:
0.000526
AC:
2
ESP6500EA
AF:
0.00207
AC:
17
ExAC
AF:
0.00218
AC:
264
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00234
EpiControl
AF:
0.00255

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsAug 30, 2017- -
Uncertain significance, criteria provided, single submitterclinical testingAthena DiagnosticsAug 31, 2017- -
Likely benign, criteria provided, single submitterclinical testingInvitaeSep 05, 2023- -
Nephrotic syndrome, type 3 Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.052
T
BayesDel_noAF
Pathogenic
0.15
CADD
Pathogenic
26
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.61
D;.;.
Eigen
Pathogenic
0.70
Eigen_PC
Pathogenic
0.73
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Uncertain
0.93
D;D;.
M_CAP
Benign
0.062
D
MetaRNN
Benign
0.026
T;T;T
MetaSVM
Uncertain
-0.20
T
MutationAssessor
Benign
1.0
L;.;.
MutationTaster
Benign
1.0
D;D;D;D
PrimateAI
Uncertain
0.57
T
PROVEAN
Uncertain
-2.7
D;D;D
REVEL
Uncertain
0.42
Sift
Pathogenic
0.0
D;D;D
Sift4G
Pathogenic
0.0
D;D;D
Polyphen
1.0
D;D;D
Vest4
0.70
MVP
0.91
MPC
0.50
ClinPred
0.073
T
GERP RS
5.8
Varity_R
0.42
gMVP
0.56

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61751493; hg19: chr10-95930939; API